Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation.
暂无分享,去创建一个
Silvia Gobbi | Maurizio Recanatini | Christina Zimmer | Federica Belluti | Rolf W Hartmann | F. Belluti | A. Bisi | S. Gobbi | M. Recanatini | A. Rampa | R. Hartmann | Christina Zimmer | Alessandra Bisi | Angela Rampa | C. Zimmer
[1] R. Hartmann,et al. Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[2] Ellis Mj,et al. First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen? , 2004 .
[3] A. Cavalli,et al. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase. , 2001, Journal of medicinal chemistry.
[4] C. Pouget,et al. New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation. , 2008, Bioorganic & medicinal chemistry.
[5] R. Bergan,et al. Phase II study of mitoxantrone and ketoconazole for hormone‐refractory prostate cancer , 2006, Cancer.
[6] A. Cavalli,et al. From nonsteroidal aromatase inhibitors to multifunctional drug candidates: classic and innovative strategies for the treatment of breast cancer. , 2008, Current topics in medicinal chemistry.
[7] W. Denny,et al. Potential antitumor agents. 62. Structure-activity relationships for tricyclic compounds related to the colon tumor active drug 9-oxo-9H-xanthene-4-acetic acid. , 1991, Journal of medicinal chemistry.
[8] Thompson Ea,et al. Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. , 1974 .
[9] V. Njar,et al. Comprehensive Pharmacology and Clinical Efficacy of Aromatase Inhibitors , 1999, Drugs.
[10] W. Denny,et al. Potential antitumor agents. 60. Relationships between structure and in vivo colon 38 activity for 5-substituted 9-oxoxanthene-4-acetic acids. , 1990, Journal of medicinal chemistry.
[11] M. E. Sousa,et al. Xanthone derivatives: new insights in biological activities. , 2005, Current medicinal chemistry.
[12] B. Potter,et al. Non‐Steroidal Aromatase Inhibitors Based on a Biphenyl Scaffold: Synthesis, in vitro SAR, and Molecular Modelling , 2008, ChemMedChem.
[13] Takashi Suzuki,et al. In situ estrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology , 2009, Pathology international.
[14] Marcy J. Balunas,et al. Isolation and Characterization of Aromatase Inhibitors from Brassaiopsis glomerulata (Araliaceae). , 2009, Phytochemistry letters.
[15] Marcy J. Balunas,et al. Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. , 2008, Journal of natural products.
[16] B. Potter,et al. Synthesis of Aromatase Inhibitors and Dual Aromatase Steroid Sulfatase Inhibitors by Linking an Arylsulfamate Motif to 4‐(4H‐1,2,4‐triazol‐4‐ylamino)benzonitrile: SAR, Crystal Structures, in vitro and in vivo Activities , 2008, ChemMedChem.
[17] Y. Na. Recent cancer drug development with xanthone structures , 2009 .
[18] B. Potter,et al. Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template. , 2010, Journal of medicinal chemistry.
[19] R. Santen,et al. History of aromatase: saga of an important biological mediator and therapeutic target. , 2009, Endocrine reviews.
[20] A. Cavalli,et al. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme. , 2006, Journal of medicinal chemistry.
[21] Silvia Gobbi,et al. Imidazolylmethylbenzophenones as highly potent aromatase inhibitors. , 2007, Journal of medicinal chemistry.
[22] R. Hartmann,et al. Synthesis of Hydroxy Derivatives of Highly Potent Non-steroidal CYP 17 Inhibitors as Potential Metabolites and Evaluation of their Activity by a Non Cellular Assay using Recombinant Human Enzyme , 2004, Journal of enzyme inhibition and medicinal chemistry.
[23] W. Denny,et al. Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the colon 38 tumor in vivo. , 1989, Journal of medicinal chemistry.
[24] J. Tobias,et al. Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer , 2008, Drugs.